The Feasibility of Immunocryosurgery in the Treatment of Non-Superficial, Facial Basal Cell Carcinoma That Relapsed after Standard Surgical Excision: An Experience Report from Two Centers

The Feasibility of Immunocryosurgery in the Treatment of Non-Superficial, Facial Basal Cell Carcinoma That Relapsed after Standard Surgical Excision: An Experience Report from Two Centers

In this retrospective, chart review study, we evaluated the feasibility of immunocryosurgery in facial, non-superficial basal cell carcinomas (BCC) that had relapsed after standard surgery. Inclusion criteria were (a) ‘biopsy confirmed relapse of facial BCC’, (b) known ‘calendar year of surgical exc...

Full description

Bibliographic Details
Main Authors: Georgios Gaitanis, Athanasia Zampeta, Panagiota Tsintzou, Grigorios Fillis, Konstantinos Seretis, Laurence Feldmeyer, Ioannis Bassukas
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Current Oncology
Subjects:
immunocryosurgery
imiquimod
cryosurgery
basal cell carcinoma
Online Access:https://www.mdpi.com/1718-7729/29/11/668

Internet

https://www.mdpi.com/1718-7729/29/11/668

Similar Items